For: | Roessler K, Mönig SP, Schneider PM, Hanisch FG, Landsberg S, Thiele J, Hölscher AH, Dienes HP, Baldus SE. Co-expression of CDX2 and MUC2 in gastric carcinomas: Correlations with clinico-pathological parameters and prognosis. World J Gastroenterol 2005; 11(21): 3182-3188 [PMID: 15929165 DOI: 10.3748/wjg.v11.i21.3182] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i21/3182.htm |
Number | Citing Articles |
1 |
Ying Wu, Zhong-wu Li, Ji-you Li. Phenotypic classification of well-differentiated gastric adenocarcinoma. Chinese Journal of Cancer Research 2009; 21(4): 278 doi: 10.1007/s11670-009-0278-2
|
2 |
Hiroko Ikeda, Motoko Sasaki, Shusaku Ohira, Akira Ishikawa, Yasunori Sato, Kenichi Harada, Yoh Zen, Yasuni Nakanuma. Tumor necrosis factor‐α induces the aberrant expression of mucus core protein‐2 in non‐neoplastic biliary epithelial cells via the upregulation of CDX2 in chronic cholangitis. Hepatology Research 2008; 38(10): 1006 doi: 10.1111/j.1872-034X.2008.00361.x
|
3 |
Abdul-Zaher M. Khattab, Wesam A. Nasif, Mahmoud Lotfy. MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis. Medical Oncology 2011; 28(S1): 207 doi: 10.1007/s12032-010-9699-5
|
4 |
Stephen A. Geller, Deepti Dhall, Randa Alsabeh. Application of Immunohistochemistry to Liver and Gastrointestinal Neoplasms: Liver, Stomach, Colon, and Pancreas. Archives of Pathology & Laboratory Medicine 2008; 132(3): 490 doi: 10.5858/2008-132-490-AOITLA
|
5 |
Russell Vang, Allen M Gown, Lee-Shu-Fune Wu, Todd S Barry, Darren T Wheeler, Anna Yemelyanova, Jeffrey D Seidman, Brigitte M Ronnett. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Modern Pathology 2006; 19(11): 1421 doi: 10.1038/modpathol.3800698
|
6 |
Yingxia Li, Libin Jiang, Zhichao Li, Yali Liu, Bo Xiao, Yan Ding, Hongtao Wen. Differences in gastric microbiota and mucosal function between patients with chronic superficial gastritis and intestinal metaplasia. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.950325
|
7 |
Qiang Liu, Ming Teh, Kosei Ito, Nilesh Shah, Yoshiaki Ito, Khay Guan Yeoh. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Modern Pathology 2007; 20(12): 1286 doi: 10.1038/modpathol.3800968
|
8 |
Julia M. Schmitz, Carolyn G. Durham, Samuel B. Ho, Robin G. Lorenz. Gastric Mucus Alterations Associated With Murine Helicobacter Infection. Journal of Histochemistry & Cytochemistry 2009; 57(5): 457 doi: 10.1369/jhc.2009.952473
|
9 |
Emmanuelle Leteurtre, Farid Zerimech, Guillaume Piessen, Agnès Wacrenier, Xavier Leroy, Marie-Christine Copin, Christophe Mariette, Jean-Pierre Aubert, Nicole Porchet, Marie-Pierre Buisine. Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World Journal of Gastroenterology 2006; 12(21): 3324-3331 doi: 10.3748/wjg.v12.i21.3324
|
10 |
Roberta Salinas-Marín, Tania M Villanueva-Cabello, Iván Martínez-Duncker. Comprehensive Glycoscience. 2021; : 237 doi: 10.1016/B978-0-12-819475-1.00082-1
|
11 |
ZHI-GANG BAI, YING-JIANG YE, DAN-HUA SHEN, YOU-YONG LU, ZHONG-TAO ZHANG, SHAN WANG. PTEN expression and suppression of proliferation are associated with Cdx2 overexpression in gastric cancer cells. International Journal of Oncology 2013; 42(5): 1682 doi: 10.3892/ijo.2013.1875
|
12 |
Kyeongmin Kim, Songmi Noh, Jae-Ho Cheong, Hyunki Kim. CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced Gastric Cancers. Gut and Liver 2021; 15(5): 694 doi: 10.5009/gnl20203
|
13 |
Sun-Young Jun, Dae Woon Eom, Hosub Park, Young Kyung Bae, Kee-Taek Jang, Eunsil Yu, Seung-Mo Hong. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. Modern Pathology 2014; 27(10): 1364 doi: 10.1038/modpathol.2014.36
|
14 |
Jung-Soo Pyo, Young San Ko, Guhyun Kang, Dong-Hoon Kim, Woo Ho Kim, Byung Lan Lee, Jin Hee Sohn. Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas. Journal of Cancer Research and Clinical Oncology 2015; 141(7): 1181 doi: 10.1007/s00432-014-1890-1
|
15 |
Takumi Sakakibara, Kenji Hibi, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera, Katsuki Ito, Akimasa Nakao. Plasminogen activator inhibitor‐1 as a potential marker for the malignancy of gastric cancer. Cancer Science 2006; 97(5): 395 doi: 10.1111/j.1349-7006.2006.00185.x
|
16 |
Mitchell S Wachtel, Yan Zhang, Maurizio Chiriva-Internati, Eldo E Frezza. Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race. BMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-65
|
17 |
Silja Wessler, Linda M. Krisch, Dominik P. Elmer, Fritz Aberger. From inflammation to gastric cancer – the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Communication and Signaling 2017; 15(1) doi: 10.1186/s12964-017-0171-4
|
18 |
Aniket Halder, Mousumi Kundu, Ram Narayan Das, Uttara Chatterjee, Chhanda Datta, Manoj Kr Choudhuri, Bitan Chatterjee. CDX2 Expression in Gastric Carcinoma: A Clinicopathological Study. Indian Journal of Medical and Paediatric Oncology 2018; 39(01): 52 doi: 10.4103/ijmpo.ijmpo_49_17
|
19 |
SHU LI, XIN CHEN, LU ZHOU, BANG-MAO WANG. Farnesoid X receptor signal is involved in deoxycholic acid-induced intestinal metaplasia of normal human gastric epithelial cells. Oncology Reports 2015; 34(5): 2674 doi: 10.3892/or.2015.4207
|
20 |
Hae‐Wan Lee, Dae H Yang, Hong K Kim, Bong H Lee, Kyung C Choi, Young H Choi, Young E Park. Expression of MUC2 in gastric carcinomas and background mucosae. Journal of Gastroenterology and Hepatology 2007; 22(8): 1336 doi: 10.1111/j.1440-1746.2007.04939.x
|
21 |
Xiao-Tong Wang, Wei-Yuan Wei, Fan-Biao Kong, Chao Lian, Wen Luo, Qiang Xiao, Yu-Bo Xie. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures. Journal of Experimental & Clinical Cancer Research 2012; 31(1) doi: 10.1186/1756-9966-31-98
|
22 |
M K Heatley. Immunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta‐analysis. Histopathology 2008; 52(3): 267 doi: 10.1111/j.1365-2559.2007.02824.x
|
23 |
A S Mall. Analysis of mucins: role in laboratory diagnosis. Journal of Clinical Pathology 2008; 61(9): 1018 doi: 10.1136/jcp.2008.058057
|
24 |
Wenbin Xiao, Hong Hong, Amad Awadallah, Lan Zhou, Wei Xin, Surinder K. Batra. Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis. PLoS ONE 2014; 9(1): e86853 doi: 10.1371/journal.pone.0086853
|
25 |
Norishige Yamada, Tomofumi Hamada, Masamichi Goto, Hideaki Tsutsumida, Michiyo Higashi, Mitsuharu Nomoto, Suguru Yonezawa. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. International Journal of Cancer 2006; 119(8): 1850 doi: 10.1002/ijc.22047
|
26 |
Quan Bao, Ni Dai, Yi-qiang Liu, Yu Sun, Xin-fu Huang, Ji-you Li. Expression of Cdx2 is associated with clinicopathologic features and prognosis of gastric carcinoma. Chinese Journal of Cancer Research 2006; 18(2): 105 doi: 10.1007/s11670-006-0105-y
|
27 |
Noha Helal, Zeinab Omran, Tarek Aboushousha, Magdy Youssef, Afkar Badawy, Ayman Abdel Aziz, Mohammed Aboul-Ezz, Mona M. Moussa. Predictive Value of CDX2 and SOX2 in Chronic Gastritis and Intestinal-type Gastric Cancer. Open Access Macedonian Journal of Medical Sciences 2020; 8(A): 947 doi: 10.3889/oamjms.2020.5570
|